RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,549,453 | +39.0% | 1,725,167 | 0.0% | 0.07% | +42.0% |
| Q2 2023 | $28,448,004 | -20.9% | 1,725,167 | -14.4% | 0.05% | -36.7% |
| Q1 2023 | $35,964,833 | -44.8% | 2,015,966 | -9.9% | 0.08% | -68.7% |
| Q4 2022 | $65,178,190 | +56.0% | 2,238,262 | +31.3% | 0.25% | +86.7% |
| Q3 2022 | $41,773,000 | +571.1% | 1,705,000 | +13.7% | 0.14% | +694.1% |
| Q2 2022 | $6,225,000 | +756.3% | 1,500,000 | +5900.0% | 0.02% | +325.0% |
| Q4 2017 | $727,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |